A Phase II Trial of Combination Thalidomide Plus Temozolomide in Patients With Metastatic Malignant Melanoma
A Phase II Trial of Combination Thalidomide Plus Temozolomide in Patients With Metastatic Malignant Melanoma
RATIONALE: Thalidomide may stop the growth of melanoma by blocking blood flow to the tumor. It may also stimulate the immune system in different ways and stop tumor cells from growing. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving thalidomide together with temozolomide may kill more tumor cells.
PURPOSE: This phase II trial is studying how well giving thalidomide together with temozolomide works in treating patients with stage IV melanoma that cannot be removed by surgery.
OBJECTIVES:
OUTLINE: This is a multicenter study.
Patients receive oral thalidomide once daily on days 1-56 and temozolomide once daily on days 1-42. Courses repeat every 56 days in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed at week 9, every 2 months until disease progression, and then every 6 months until 3 years from study entry.
PROJECTED ACCRUAL: A total of 55 patients will be accrued for this study within 14 months.
DISEASE CHARACTERISTICS:
Histologically confirmed malignant cutaneous melanoma
Measurable or non-measurable disease
No brain metastases by CT scan or MRI within the past 42 days
Prior brain metastasis allowed provided both of the following criteria are met:
PATIENT CHARACTERISTICS:
Age
Performance status
Life expectancy
Hematopoietic
Hepatic
Renal
Other
PRIOR CONCURRENT THERAPY:
Biologic therapy
Chemotherapy
Endocrine therapy
Radiotherapy
Surgery
Other
Little Rock, Arkansas 72205, United States
Los Angeles, California 90089-9181, United States
Oakland, California 94602, United States
Pensacola, Florida 32514, United States
Savannah, Georgia 31403-3089, United States
Maywood, Illinois 60153, United States
Mount Clemens, Michigan 48043, United States
Billings, Montana 59101, United States
Missoula, Montana 59807, United States
Middletown, New York 10940-4199, United States
Rochester, New York 14642, United States
Westerville, Ohio 43081, United States
Portland, Oregon 97210, United States
Portland, Oregon 97213-2967, United States
Portland, Oregon 97227, United States
Spartanburg, South Carolina 29303, United States
Knoxville, Tennessee 37920-6999, United States
Seattle, Washington 98122-4307, United States
Seattle, Washington 98195-6043, United States
Parkersburg, West Virginia 26102, United States